Michael A. Caligiuri, M.D.
Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief.
Widely recognized as a health care visionary, Caligiuri is president of the American Association for Cancer Research. He will join City of Hope in February 2018.
“This is an extraordinary time in cancer research and care. Every day brings exciting new discoveries and innovations, and City of Hope is at the forefront of groundbreaking work that will define new standards of care,” said Robert W. Stone
, City of Hope’s president and chief executive officer. “Dr. Caligiuri is an exceptional and accomplished leader who will join and lead an extraordinary group of talented individuals singularly focused on eradicating cancer and diabetes. As I have come to know him, I have been struck by his innovative approach to science, high degree of humility and dedication to serving patients in need — all of which fit perfectly with City of Hope.”
In this new role, Caligiuri will be responsible for driving innovation in cancer care and delivery. Specifically, he will encourage and develop new paradigms for translating state-of-the-art research into practice at City of Hope, the community and beyond. He will also be responsible for optimizing the patient care system to ensure the highest quality and safest patient experience.
Most recently, Caligiuri was director of The Ohio State University Comprehensive Cancer Center and CEO of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio, leading the institution to remarkable research and clinical achievements.
As a physician-scientist, he is well-known for work in immunology that focuses on human natural killer cells and their modulation for the treatment of leukemia, myeloma and glioblastoma. More than 1,500 cancer patients have been treated on clinical protocols that have emanated from the Caligiuri laboratory.
“City of Hope is an incredible institution with an amazing history of innovation,” Caligiuri said. “I have many friends and colleagues at City of Hope and I am incredibly excited about the organization’s vision. I share that vision and excitement for the role City of Hope will play in changing the global landscape of cancer care.”
“We make this critical appointment at a time when cancer discoveries hold tremendous promise for patients worldwide,” Stone said. “Together, we are committed to being at the center of eliminating cancer and diabetes by bringing tomorrow’s discoveries to the patients who need them today.”